INTERNATIONAL PATENT: REDNVIA CO., LTD., 주식회사 레드엔비아 FILES APPLICATION FOR "COMBINATORY FORMULATION COMPRISING SGLT-2 INHIBITOR AND DPP-4 INHIBITOR FOR PREVENTING OR TREATING VASCULAR OR VALVULAR STENOSIS"

GENEVA, May 6 -- REDNVIA CO., LTD. (88 Olympic-ro 43-gil,Songpa-gu,Seoul 05505), 주식회사 레드엔비아 (서울특별시송파구올림픽로43길 88) filed a patent application (PCT/KR2024/096387) for "COMBINATORY FORMULATION COMPRISING SGLT-2 INHIBITOR AND DPP-4 INHIBITOR FOR PREVENTING OR TREATING VASCULAR OR VALVULAR STENOSIS" on Oct 24, 2024. With publication no. WO/2025/089933, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organizatio...